Researchers at the Vancouver Prostate Center have developed a new blood test that provides unprecedented insight into a patient's cancer make-up, potentially allowing doctors to better select treatment options that will improve ...
Jul 20, 2022
0
1924
A new research study showed that circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery ...
Jun 4, 2022
0
739
Researchers at City of Hope, a world-renowned cancer research and treatment organization, have identified a pathway that explains how mutated cancer cells can continue to replicate and become resistant to oncology therapies.
Dec 2, 2021
0
475
A newly discovered mechanism at work in human immunodeficiency virus (HIV) patients may also lead to new treatments for COVID-19, according to a team of researchers at the University of Alberta.
Jul 31, 2020
0
928
Researchers from The Australian National University (ANU) have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global ...
May 6, 2022
0
79
A new study has found that a commonly prescribed antidepressant may halt growth of a type of cancer known as childhood sarcoma, at least in mice and laboratory cell experiments. The findings, from researchers at Karolinska ...
Nov 6, 2020
0
271
A team of researchers from Baidu Research has developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable. The algorithm, named LinearDesign, represents ...
May 2, 2023
0
68
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according ...
Dec 7, 2020
0
339
The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial.
Jan 3, 2022
0
19
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or in combination with another anticancer drug (pembrolizumab) may be effective in treating several types of late-stage cancers ...
May 26, 2022
0
20
